Focus Advisor Solutions LLC lifted its position in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) by 98.7% during the third quarter, Holdings Channel reports. The institutional investor owned 25,663 shares of the financial services provider’s stock after buying an additional 12,746 shares during the quarter. Focus Advisor Solutions LLC’s holdings in Marsh & McLennan Companies were worth $4,382,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the company. BlackRock Inc. acquired a new position in Marsh & McLennan Companies during the second quarter worth about $6,583,806,000. Corient Private Wealth LP acquired a new stake in Marsh & McLennan Companies in the 2nd quarter valued at about $66,475,000. Deutsche Bank AG acquired a new stake in Marsh & McLennan Companies in the 2nd quarter valued at about $685,621,000. Bank of America Corp DE bought a new position in shares of Marsh & McLennan Companies during the 2nd quarter valued at about $575,845,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Marsh & McLennan Companies in the 2nd quarter worth approximately $532,438,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
Recent Marsh & McLennan Companies Headlines
Investors following MRSH have been watching these headlines:
- Positive Sentiment: Wells Fargo upgraded MRSH from “equal weight” to “overweight” and raised its price target to $235 from $197, signaling greater confidence in the shares. Wells Fargo rating information
- Positive Sentiment: A separate valuation article argues MRSH could trade below fair value, offering a potentially supportive view of the stock, although the supplied headline gives no valuation assumptions. Valuation article
- Neutral Sentiment: Marsh’s prominent presence at the Las Vegas Grand Prix as Formula 1’s official risk and insurance-brokering partner may support brand visibility, but no direct financial effect was disclosed. Marsh Formula 1 announcement
Marsh & McLennan Companies Price Performance
MRSH stock opened at $206.22 on Friday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.09 and a quick ratio of 1.09. The firm has a market capitalization of $98.06 billion, a price-to-earnings ratio of 24.67, a P/E/G ratio of 2.84 and a beta of 0.53. Marsh & McLennan Companies, Inc. has a 52-week low of $156.60 and a 52-week high of $214.00. The company’s 50 day moving average price is $188.18.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its quarterly earnings data on Thursday, October 15th. The financial services provider reported $2.03 EPS for the quarter, topping analysts’ consensus estimates of $1.96 by $0.07. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. The firm had revenue of $6.86 billion during the quarter. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. Sell-side analysts predict that Marsh & McLennan Companies, Inc. will post 10.49 EPS for the current fiscal year.
Marsh & McLennan Companies Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Thursday, October 1st were given a $0.99 dividend. This represents a $3.96 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend was Thursday, October 1st. Marsh & McLennan Companies’s dividend payout ratio (DPR) is 47.37%.
Analyst Ratings Changes
Several research firms have issued reports on MRSH. Citigroup upped their price target on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “neutral” rating in a report on Friday, October 16th. Morgan Stanley raised their price objective on Marsh & McLennan Companies from $190.00 to $215.00 and gave the stock an “equal weight” rating in a research note on Monday, November 16th. Jefferies Financial Group decreased their target price on Marsh & McLennan Companies from $193.00 to $188.00 and set a “hold” rating on the stock in a report on Wednesday, September 30th. BMO Capital Markets upgraded Marsh & McLennan Companies from a “market perform” rating to an “outperform” rating and increased their price target for the company from $204.00 to $230.00 in a research report on Tuesday, November 3rd. Finally, UBS Group lifted their price target on Marsh & McLennan Companies from $216.00 to $222.00 and gave the stock a “buy” rating in a research note on Tuesday, October 6th. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $210.63.
View Our Latest Analysis on MRSH
Insider Buying and Selling at Marsh & McLennan Companies
In related news, VP Stacy Mills sold 1,215 shares of the stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $243,000.00. Following the completion of the sale, the vice president directly owned 2,705 shares of the company’s stock, valued at approximately $541,000. This represents a 30.99% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Dean Klisura sold 4,194 shares of the stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $838,800.00. Following the completion of the sale, the chief executive officer directly owned 20,935 shares of the company’s stock, valued at approximately $4,187,000. This represents a 16.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
About Marsh & McLennan Companies
Marsh & McLennan Companies, now known as Marsh, is a professional services firm focused on risk, strategy and people. Its businesses help organizations assess and manage risk, arrange insurance and reinsurance, and address workforce and organizational challenges. The company operates through Marsh, an insurance brokerage and risk advisory business; Guy Carpenter, which specializes in reinsurance and related risk services; Mercer, which provides health, wealth and career consulting; and Oliver Wyman, a management consulting firm.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
